These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35240329)

  • 1. Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood.
    Wu JF; Tai CS; Chang KC; Chen HL; Ni YH; Hsu HY; Chang MH
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):663-669.e1. PubMed ID: 35240329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients.
    Zhang ZQ; Shi BS; Lu W; Liu DP; Huang D; Feng YL
    Gastroenterol Hepatol; 2020 Nov; 43(9):526-536. PubMed ID: 32921478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
    Chuaypen N; Posuwan N; Payungporn S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
    Liver Int; 2016 Jun; 36(6):827-36. PubMed ID: 26678018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.
    Wong DK; Seto WK; Cheung KS; Chong CK; Huang FY; Fung J; Lai CL; Yuen MF
    Liver Int; 2017 Jul; 37(7):995-1001. PubMed ID: 27992681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study.
    Xu B; Liu A; Liu Y; Han T; Guo H; Ding X; Xiang H
    J Int Med Res; 2022 Oct; 50(10):3000605221130714. PubMed ID: 36224762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy.
    Chuaypen N; Posuwan N; Chittmittraprap S; Hirankarn N; Treeprasertsuk S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
    Clin Microbiol Infect; 2018 Mar; 24(3):306.e7-306.e13. PubMed ID: 28750917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
    Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
    Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA.
    Chen EQ; Wang ML; Tao YC; Wu DB; Liao J; He M; Tang H
    J Viral Hepat; 2019 May; 26(5):586-595. PubMed ID: 30632235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet counts modulate the quantitative relationship between hepatitis B viral DNA and surface antigen concentrations: a cross-sectional study of hematological, histological and viral factors.
    Hsu CW; Liang KH; Lin CL; Wang TH; Yeh CT
    BMC Infect Dis; 2017 Jan; 17(1):9. PubMed ID: 28056849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum HBV RNA is associated with liver fibrosis regression in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues.
    Bian D; Zhao J; Liao H; Wang Y; Ren Y; Jiang Y; Liu S; Chen X; Hu Z; Duan Z; Lu F; Zheng S
    J Viral Hepat; 2023 Apr; 30(4):303-309. PubMed ID: 36533536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B.
    Chang XJ; Sun C; Chen Y; Li XD; Yu ZJ; Dong Z; Bai WL; Wang XD; Li ZQ; Chen D; Du WJ; Liao H; Jiang QY; Sun LJ; Li YY; Zhang CH; Xu DP; Chen YP; Li Q; Yang YP
    World J Gastroenterol; 2019 Aug; 25(32):4764-4778. PubMed ID: 31528100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
    Ghany MG; King WC; Lisker-Melman M; Lok ASF; Terrault N; Janssen HLA; Khalili M; Chung RT; Lee WM; Lau DTY; Cloherty GA; Sterling RK
    Hepatology; 2021 Nov; 74(5):2395-2409. PubMed ID: 34133774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B Patients.
    Suzuki T; Matsuura K; Inoue T; Sasada K; Ogawa S; Watanabe T; Kawamura H; Fujiwara K; Kataoka H; Tanaka Y
    J Med Virol; 2024 Jul; 96(7):e29816. PubMed ID: 39015036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.
    Yan LB; Zhu X; Bai L; Tang XQ; Du LY; Chen EQ; Liang LB; Tang H
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):296-302. PubMed ID: 27988305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients.
    Ahmed FA; Bajaifar MS; Ahmed MA; Alalwan A; Sanai FA; Albeladi K; Aljumah AA; Sanai FM
    Saudi J Gastroenterol; 2019; 25(5):286-292. PubMed ID: 31044750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy.
    Erken R; Zaaijer HL; Willemse SB; Bakker E; Takkenberg BB; Reesink HW; Kootstra NA
    Ann Hepatol; 2021 Dec; 26():100540. PubMed ID: 34583061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.
    Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
    Hepatol Commun; 2021 Nov; 5(11):1873-1887. PubMed ID: 34558823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.